Literature DB >> 8971402

Impact of myeloablative therapy with bone marrow transplantation in advanced neuroblastoma.

K K Matthay1.   

Abstract

Current results suggest that purged autologous bone marrow transplant may improve outcome for some subsets of high risk neuroblastoma, but the risk of relapse is still high.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8971402

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


  4 in total

Review 1.  Stem cell transplantation for neuroblastoma.

Authors:  J D Fish; S A Grupp
Journal:  Bone Marrow Transplant       Date:  2007-11-26       Impact factor: 5.483

Review 2.  Neuroblastoma: issues in transplantation.

Authors:  Stephan A Grupp; Shahab Asgharzadeh; Gregory A Yanik
Journal:  Biol Blood Marrow Transplant       Date:  2012-01       Impact factor: 5.742

Review 3.  Autologous and allogeneic cellular therapies for high-risk pediatric solid tumors.

Authors:  David Barrett; Jonathan D Fish; Stephan A Grupp
Journal:  Pediatr Clin North Am       Date:  2010-02       Impact factor: 3.278

Review 4.  High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.

Authors:  Bilgehan Yalçin; Leontien C M Kremer; Elvira C van Dalen
Journal:  Cochrane Database Syst Rev       Date:  2015-10-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.